Search Results - "Olson, Marissa"

A Single Center Retrospective Analysis of Letermovir for Cytomegalovirus Prophylaxis after Allogeneic Stem Cell Transplant in Cytomegalovirus Seropositive Recipients or Donors by Liu, Lawrence, Yn, Alicia, Gao, Feng, Olson, Marissa, Crain, Mallory, Schroeder, Mark A.

“…Background: Up to 70% of allogeneic stem cell transplant (alloSCT) recipients who are cytomegalovirus (CMV) seropositive experience CMV reactivation and up to…”
Get full text

Abstract 5490: Implementation of genetic sequencing in breast and ovarian cancer patients: a cost analysis by Olson, Marissa A., Tutera, Seth, Williams, Casey

“…Abstract Purpose: Genetic sequencing has the ability to identify and treat the driving mechanisms of cancer. As a result, practitioners can individualize…”
Get full text

Effects of Implementing a Standardized Surveillance Program on Cardiac Neurodevelopmental Program Referral Completion by Hennrick, Heather, Miller, Elizabeth, Lai, Wyman W., Nelkin, Viannae Carmona, Flores, Ana-Mercedes, Olson, Marissa, Kong, Dianne, Tan, Alexander

“…Differences in surveillance methods have resulted in significant variability in referral volumes and referral completion rates across cardiac…”
Get full text

The use of ruxolitinib for acute graft‐versus‐host disease developing after solid organ transplantation by Jacobs, Miriam T., Olson, Marissa, Ferreira, Bruna Pellini, Jin, Ramon, Hachem, Ramsey, Byers, Derek, Witt, Chad, Ghobadi, Armin, DiPersio, John F., Pusic, Iskra

“…Development of graft‐versus‐host disease (GvHD) is a rare complication after transfusions or solid organ transplantation. Patients typically present with a…”
Get full text

The Effect of Visual Feedback on Vocal Compensation Abilities in Individuals With Post-stroke Aphasia by Olson, Marissa Rylee

“…Speech production is a complex and highly organized process comprised of various sensory and perceptual components. Post-stroke aphasia can impair speech…”
Get full text

Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related Mortality by Liu, Lawrence Wayne, Yn, Alicia, Gao, Feng, Olson, Marissa, Crain, Mallory, Abboud, Ramzi, Westervelt, Peter, Abboud, Camille, Vij, Ravi, Stockerl-Goldstein, Keith, Pusic, Iskra, Cashen, Amanda F., Schroeder, Mark A.

“…Letermovir is approved by the Food and Drug Administration for cytomegalovirus (CMV) prophylaxis in CMV seropositive recipients of allogeneic stem cell…”
Get full text

Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia by Benitez, Lydia L., Perissinotti, Anthony J., Rausch, Caitlin R., Klaus, Jeff, Clark, Stephen Michael, Filtz, Michael, Ratermann, Kelley, Treptow, Carissa, Griffin, Shawn, Olson, Marissa, Crain, Mallory, Kadia, Tapan, Pettit, Kristen, Burke, Patrick W., Bixby, Dale L., Marini, Bernard L.

“…Liposomal daunorubicin/cytarabine (CPX-351) gained FDA approval for secondary AML after demonstrating improved outcomes over daunorubicin and cytarabine (7 +…”
Get full text

Multi-Center Retrospective Evaluation of High-Dose Cytarabine Based Induction Versus CPX-351 Induction in Patients with Secondary AML by Benitez, Lydia, Perissinotti, Anthony J., Rausch, Caitlin R., Klaus, Jeff, Clark, Stephen Michael, Filtz, Michael, Ratermann, Kelley L, Treptow, Carissa F., Griffin, Shawn, Olson, Marissa, Crain, Mallory, Pettit, Kristen, Burke, Patrick W., Bixby, Dale L., Marini, Bernard Lawrence

“…BACKGROUND Secondary AML (sAML) that develops after an antecedent hematologic disorder or exposure to genotoxic therapy is associated with a poor prognosis and…”
Get full text

A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma by Cortese, Matthew J., Wei, Wei, Cerdeña, Sebastian, Watkins, Marcus P., Olson, Marissa, Jodon, Gray, Kaiser, Jeff, Haverkos, Bradley, Hughes, Mitchell E., Namoglu, Esin, Grover, Natalie S., Snow, Anson, Orellana-Noia, Victor, Rainey, Magdalena, Sohail, Mohammad, Rudoni, Joslyn, Portell, Craig, Voorhees, Timothy, Landsburg, Daniel J., Kamdar, Manali, Kahl, Brad S., Hill, Brian T.

“…Patients with double- and triple-hit lymphomas (DHL/THL) have inferior outcomes with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone…”
Get full text

A Multi-Center Analysis of the Impact of Dose Level of R-EPOCH on Outcomes of Patients with Double/Triple-Hit B-Cell Lymphoma by Cortese, Matthew J, Wei, Wei, Cerdena, Sebastian, Watkins, Marcus, Olson, Marissa, Jodon, Gray, Kaiser, Jeff, Haverkos, Bradley, Hughes, Mitchell E., Grover, Natalie S, Snow, Anson, Orellana-Noia, Victor M., Rainey, Magdalena A, Sohail, Mohammad Ahsan, Rudoni, Joslyn, Portell, Craig A., Voorhees, Timothy J, Landsburg, Daniel J., Kamdar, Manali, Kahl, Brad S., Hill, Brian T.

“…BACKGROUND: High-grade B-cell lymphomas (HGBLs) with rearrangement of MYC and BCL2 and/or BCL6, known as “double-hit” or “triple-hit” B-cell lymphomas…”
Get full text

Patterns and Risk of CNS Recurrence after R-EPOCH Treatment for Double/Triple Hit Lymphoma by Sohail, Mohammad Ahsan, Li, Hong, Wei, Wei, Cerdena, Sebastian, Watkins, Marcus, Olson, Marissa, Jodon, Gray, Kaiser, Jeff, Haverkos, Bradley, Hughes, Mitchell E., Grover, Natalie S, Snow, Anson, Orellana-Noia, Victor M., Rainey, Magdalena A, Cortese, Matthew J, Rudoni, Joslyn, Portell, Craig A., Voorhees, Timothy J, Landsburg, Daniel J., Kamdar, Manali, Kahl, Brad S., Hill, Brian T.

“…BACKGROUND: Central nervous system (CNS) relapse in systemic non-Hodgkin's lymphoma is associated with a guarded prognosis with a median survival of only 2-6…”
Get full text

Abstract 5494: Cost analysis of genomic-directed therapy in patients with metastatic lung and colorectal cancers by Tutera, Seth, Olson, Marissa, Williams, Casey, Leyland-Jones, Brian, Huber, Mark, McKean, Heidi, Tolentino, Addison

“…Abstract Purpose Cancer represents a significant burden on the economy. The NCI estimated that this cost will exceed $158 billion in 2020. As cancer-related…”
Get full text